Results 91 to 100 of about 877,857 (301)
Loss of AMBRA1 activates MAPK and angiogenesis signaling pathways in melanoma cells
Loss of AMBRA1 in melanoma cells activates multiple oncogenic pathways associated with tumor progression. Transcriptomic and protein network analyses revealed that AMBRA1 depletion enhances MAPK/ERK signaling, angiogenesis, TGF‐β/EMT signaling, and Wnt/axon guidance pathways.
Milad Ibrahim +4 more
wiley +1 more source
Factors Affecting Late Introduction of Complementary Food: A Kaplan Meier Analysis
Introduction: Late introduction of complementary food is associated with malnutrition and in India about 47% of children are given complementary food at age ≥6 months.
V M Holambe, N A Thakur
doaj
Kaplan-Meier curves (survival—shopping duration).
Kaplan-Meier curves (survival—shopping duration).
Jie Ma (166937) +2 more
core +1 more source
This prospective study demonstrates that laparoscopic sphincter‐preserving surgery is feasible for elderly patients. While overall survival reaches 70% at 5 years, advanced T‐stage and the omission of neoadjuvant therapy significantly drive recurrence, highlighting the need for personalized geriatric protocols despite logistical challenges.
Huu Duc Ho +4 more
wiley +1 more source
Kaplan-Meier estimator for agri-food products.
Kaplan-Meier estimator for agri-food products.
Ping Wang (42415) +3 more
core +1 more source
In patients with malignant ureteral obstruction undergoing percutaneous nephrostomy, sarcopenia defined by a low psoas muscle index was independently associated with poor overall survival on multivariate Cox regression analysis, suggesting that preoperative assessment of psoas muscle index may aid prognostic stratification in this population.
Kota Shimokihara +3 more
wiley +1 more source
Kaplan-Meier recovery estimates by sex.
Kaplan-Meier recovery estimates by sex.
Sharon Fonn (5520593) +2 more
core +1 more source
Kaplan-Meier survival estimates by viraemic-time.
Kaplan-Meier survival estimates by viraemic-time.
Tom Decroo (540062) +16 more
core +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi +9 more
wiley +1 more source

